Interestingly, eEF2 was identified as a tumor-associated antigen, and eEF2-derived polypeptides are immunogenic and induce activated CD8+ T cells or cytotoxic T lymphocytes in vitro, suggesting potential adoptive transfer cancer immunotherapeutic for colon cancer [212]. Here, EEF2 is linked to neoplasm.